Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 263


Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.

Gibby K, You WK, Kadoya K, Helgadottir H, Young LJ, Ellies LG, Chang Y, Cardiff RD, Stallcup WB.

Breast Cancer Res. 2012 Apr 24;14(2):R67.


NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.

You WK, Yotsumoto F, Sakimura K, Adams RH, Stallcup WB.

Angiogenesis. 2014 Jan;17(1):61-76. doi: 10.1007/s10456-013-9378-1. Epub 2013 Aug 8.


CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation.

Gerstel D, Wegwitz F, Jannasch K, Ludewig P, Scheike K, Alves F, Beauchemin N, Deppert W, Wagener C, Horst AK.

Oncogene. 2011 Oct 13;30(41):4275-88. doi: 10.1038/onc.2011.146. Epub 2011 May 2.


Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.

Denzel MS, Hebbard LW, Shostak G, Shapiro L, Cardiff RD, Ranscht B.

Clin Cancer Res. 2009 May 15;15(10):3256-64. doi: 10.1158/1078-0432.CCR-08-2661. Epub 2009 May 15.


Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.

Huang FJ, You WK, Bonaldo P, Seyfried TN, Pasquale EB, Stallcup WB.

Dev Biol. 2010 Aug 15;344(2):1035-46. doi: 10.1016/j.ydbio.2010.06.023. Epub 2010 Jun 27.


Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.

Landskroner-Eiger S, Qian B, Muise ES, Nawrocki AR, Berger JP, Fine EJ, Koba W, Deng Y, Pollard JW, Scherer PE.

Clin Cancer Res. 2009 May 15;15(10):3265-76. doi: 10.1158/1078-0432.CCR-08-2649. Epub 2009 May 15.


Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.

Roselli S, Kahl RG, Copeland BT, Naylor MJ, Weidenhofer J, Muller WJ, Ashman LK.

BMC Cancer. 2014 Jul 11;14:509. doi: 10.1186/1471-2407-14-509.


Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.

Sevenich L, Werner F, Gajda M, Schurigt U, Sieber C, Müller S, Follo M, Peters C, Reinheckel T.

Oncogene. 2011 Jan 6;30(1):54-64. doi: 10.1038/onc.2010.387. Epub 2010 Sep 6.


NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization.

Yotsumoto F, You WK, Cejudo-Martin P, Kucharova K, Sakimura K, Stallcup WB.

Oncoimmunology. 2015 Jan 22;4(4):e1001204. eCollection 2015 Apr.


Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.

Heckman-Stoddard BM, Vargo-Gogola T, McHenry PR, Jiang V, Herrick MP, Hilsenbeck SG, Settleman J, Rosen JM.

Breast Cancer Res. 2009;11(4):R61. doi: 10.1186/bcr2352. Epub 2009 Aug 24.


NG2 Proteoglycan-dependent contributions of pericytes and macrophages to brain tumor vascularization and progression.

Stallcup WB, You WK, Kucharova K, Cejudo-Martin P, Yotsumoto F.

Microcirculation. 2015 Oct 14. doi: 10.1111/micc.12251. [Epub ahead of print]


Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.

Roussos ET, Wang Y, Wyckoff JB, Sellers RS, Wang W, Li J, Pollard JW, Gertler FB, Condeelis JS.

Breast Cancer Res. 2010;12(6):R101. doi: 10.1186/bcr2784. Epub 2010 Nov 25.


Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.

Miwa HE, Koba WR, Fine EJ, Giricz O, Kenny PA, Stanley P.

Glycobiology. 2013 Dec;23(12):1477-90. doi: 10.1093/glycob/cwt075. Epub 2013 Sep 13.


The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.

J Clin Invest. 2008 Jan;118(1):64-78.


Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.

Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET.

Cancer Res. 2004 Sep 1;64(17):5973-81.


Collagen VI ablation retards brain tumor progression due to deficits in assembly of the vascular basal lamina.

You WK, Bonaldo P, Stallcup WB.

Am J Pathol. 2012 Mar;180(3):1145-58. doi: 10.1016/j.ajpath.2011.11.006. Epub 2011 Dec 23.


Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.

Smith MJ, Berger RW, Minhas K, Moorehead RA, Coomber BL.

Int J Exp Pathol. 2011 Apr;92(2):106-16. doi: 10.1111/j.1365-2613.2010.00748.x. Epub 2010 Nov 8.


Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.

Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.

Cancer Res. 2006 Mar 1;66(5):2691-9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk